Muscle Stimulation Devices Market Size and Forecast — 2026-2033
Muscle Stimulation Devices Market is estimated to be valued at USD 848.3 Mn in 2026 and is expected to reach USD 1,116.3 Mn in 2033, exhibiting a compound annual growth rate (CAGR) of 4.0% from 2026 to 2033.
Analysts’ Views on Global Muscle Stimulation Devices Market:
To enable a platform that is rapid, efficient sample processing and the market is being driven primarily by the rising prevalence of musculoskeletal disorders and the increasing trend of physical fitness worldwide. Muscle stimulators are medical devices that use electrical impulses to contract muscles, helping to reduce pain, increase muscle strength, and promote muscle relaxation. Global muscle stimulation devices market over the forecast period. For instance, in April 2021, Therabody, Inc. is wellness technology company, announced that it has acquired the PowerDot. Smart Muscle Stimulator. It is use for neuromuscular electrical stimulation (NMES) and transcutaneous electrical nerve stimulation (TENS) send electronic pulses to stimulate motor nerves to create muscle contraction and stimulate sensory nerves to temporarily relieve pain.
Figure 1. Global Muscle Stimulation Devices Market Share (%), by Product Type, 2026

Global muscle stimulation devices market – Driver
Increasing incidence of head and spinal cord injuries
Increasing incidence of head and spinal cord injuries is expected to boost growth of the global muscle stimulation devices market over the forecast period. For instance, According to National Library of Medicine in May 2022, Globally, between 250,000 and 500,000 patients, each year suffer a spinal cord injury. Most of these cases are due to preventable causes such as violence and motor vehicle accidents. In the U.S., there are approximately 17,000 new cases of spinal cord injuries each year, and roughly 282,000 persons are estimated to be living with spinal cord injuries.
Figure 2. Global Muscle Stimulation Devices Market Value (US$ Million), by Region, 2026

Global Muscle Stimulation Devices Market- Regional Analysis
Among regions, North America is estimated to hold a dominant position in the global muscle stimulation devices market over the forecast period. North America is estimated to hold 47.5% of the market share in 2026. The North America muscle stimulation devices market is expected to witness significant growth in the coming years, driven by factors such as the increasing prevalence of musculoskeletal disorders and the rising demand for non-invasive and drug-free pain management therapies Thus, the rise in muscle stimulation devices market growth over the forecast period.
- Current Industry Events of 2026
- Market Size Estimation
- Regional Breakdown
- Competitive Landscape
- Customer Intelligence
- Segmental Analysis
- Pricing Analysis
- Key Market Drivers, Challenges & Future Trends
- Customized Insights Section
Muscle Stimulation Devices Market Report Coverage
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 848.3 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.0% | 2033 Value Projection: | USD 1,116.3 Mn |
| Geographies covered: |
| ||
| Segments covered: |
| ||
| Companies covered: | Baptist Health, DJO Global Inc., Zynex Inc., Neurometrix Inc., R.S. Medical Inc.,Omron Corporation Medtronic plc., Abbott., Boston Scientific Corporation., BTL Corporate., Nevro Corp., Cogentix Medical and BioMedical Life Systems. | ||
| Growth Drivers: |
| ||
| Restraints & Challenges: |
| ||
Global Muscle Stimulation Devices Market Segmentation:
The global muscle stimulation devices market report is segmented into by Product Type, by Application, By End User and Region.
By Product Type, the market is segmented into Transcutaneous electrical nerve stimulation (tens), Interferential current electrical stimulation (ifc), Burst mode alternating current (bmac), Neuromuscular electrical stimulation (nmes) . Out of which, the into Transcutaneous Electrical Nerve Stimulation (TENS) segment is expected to hold a dominant position in the global muscle stimulation devices market during the forecast period and this is attributed to the technological advancements in the field of Muscle Stimulation Devices.
By Application, the market is segmented into Pain management, neurological and movement disorder management, and musculoskeletal disorder management. Out of which, the into Pain Management segment is expected to hold a dominant position in the Muscle Stimulation Devices market during the forecast period and this is attributed to the increasing prevalence of .
By End User , the market is segmented into Hospitals, Physiotherapy Clinics, Sports Clinics, and Home Care . Out of which, the Physiotherapy Clinics is expected to dominate the market over the forecast period and this is attributed to the increasing prevalence of Neurological and Movement Disorder.
Among all the segmentations, the product type segment has the highest potential due to the increasing prevalence of neurological and movement disorder over the forecast period. Baptist Health neurologist and neurosurgeon work with Medtronic to offer minimally invasive treatment for placement of deep brain stimulation neurotransmitters to individualize care for patients based on their neurological condition. Deep brain stimulation (DBS) devices are effective for managing movement disorders such as Parkinson’s disease and other neurological conditions, Baptist Health worked with Medtronic to pioneer an innovative medical device aimed at improving quality of life for patients with severe neurologic disorders.
Global Muscle Stimulation Devices Market Cross Sectional Analysis:
Rising incidence of Neurological and Movement Disorder in emerging economies is also expected to boost demand for muscle stimulant device technologies in North America region. For instance, in May 2021, Zynex Inc is manufacturing and marketing of medical devices, launched NeuroMove is U.S. FDA-cleared for stroke rehabilitation, and its use has dramatically ameliorated functional impairments in stroke survivors in many clinical studies and in the clinical practice.
Global Muscle Stimulation Devices Market: Key Developments
In May 2021, ITO CO., LTD., is Japan-based engineering and manufacturers and electrophysical agents announced that electrical muscle stimulator for TMJ (temporomandibular joint) Pain Relief "D function" had received 510(k) clearance by the U.S. FDA. Its use for Prevents and reveres muscle atrophy (loss of muscle mass/tissue) Enhances rehabilitation of muscles. Increases range of motion for tense muscles or tendons. Reduces stress and discomfort.
In September 2021, NCS America, Inc., is a medical technology company announced that U.S. Food and Drug Administration (FDA) cleared the Shoulder Pacemaker and its unique Motion Activated Stimulation (MAS) technology. The Shoulder Pacemaker is an innovative wearable electro stimulator created for patients suffering from unbalanced muscle activation in the shoulder.
In October 2022, Medtronic is a medical technology, services, and solutions. The Company launched Medtronic Neurovascular Co-Lab Platform to accelerate innovation in stroke treatment. Neurovascular Co-Lab Platform drives collaboration and connections among start-ups, physicians, and institutions; aims to improve stroke treatment and access for patients worldwide.
In July 2021, Neurolief, an Israel-based neuromodulation company and NeuroFront, a clinical stage biotech company, announced an exclusive licensing agreement for NeuroFront to develop and commercialize Relivion, non-invasive medical devices for the treatment of migraine and depression, in China and South Korea.
Global Muscle Stimulation Devices Market: Key Trends
Rising demand of stimulation device, increasing need to treat paralytic patients and surging demand of combination therapy can drive the growth of market
Rising demand of stimulation device, increasing need to treat paralytic patients and surging demand of combination therapy, the muscle stimulation devices market is expected to experience considerable expansion in the North American region. For instance, on April 10, 2023, Reach Neuro, Inc. is Medical equipment manufacturer in Pittsburgh, Pennsylvania. received breakthrough device designation from the U.S. Food and Drug Administration (FDA) for its Avantis system directly restores a patient’s ability to control movement and upper body paralysis treatment for stroke patients.
Global Muscle Stimulation Devices Market: Restraint
Side effects of transcutaneous electrical nerve stimulation (TENS) therapy
Side effects of transcutaneous electrical nerve stimulation (TENS) therapy is slated to hinder market expansion. The side effects associated with transcutaneous electrical nerve stimulation therapy include buzzing, tingling, or prickling sensation, which some people may find uncomfortable as TENS unit produces electrical impulses.
Global Muscle Stimulation Devices Market - Key Players
Major players operating in the global muscle stimulation devices market include DJO Global Inc., Zynex Inc., Neurometrix Inc., R.S. Medical Inc., Omron Corporation Medtronic plc., Abbott., Boston Scientific Corporation., BTL Corporate., Nevro Corp., Cogentix Medical , Acumedical , Beijing Electronics Holding, Enovis, Nasophlex and BioMedical Life Systems.
Sources
Primary Research Interviews
- Electrical muscle stimulation (EMS) device manufacturers (e.g., Compex/DJO, Marc Pro, PowerDot, Globus Corporation, Omron Healthcare)
- Sports medicine clinicians, physical therapists and athletic trainers
- Home fitness and rehab e-commerce channels
Databases
- U.S. FDA 510(k) physical medicine device database
- CMS HCPCS electrical stimulation coding
- EUDAMED device registrations
Magazines
- Rehab Management
- Athletic Business
Journals
- Journal of Strength and Conditioning Research (NSCA)
- Archives of Physical Medicine and Rehabilitation (Elsevier)
Newspapers
- Reuters Health
- Financial Times – Consumer
Associations
- American Physical Therapy Association (APTA)
- National Strength and Conditioning Association (NSCA)
- American College of Sports Medicine (ACSM)
Public Domain Sources
- U.S. FDA guidance on powered muscle stimulators
- NICE musculoskeletal guidelines
- ResearchGate publications on neuromuscular electrical stimulation
Proprietary Elements
- CMI Data Analytics Tool, Proprietary CMI Existing Repository of information for last 10 years.
*Definition: Muscle Stimulation Devices is a study of electrical muscle stimulation to help treat pain and heal injured, weak, or diseased muscles. The electrical currents may help improve blood flow and stimulate the muscle fibers or nerves.Physicians may recommend TENS or EMS depending on the injury or condition.EMS may help the muscles respond to natural signals to contract. This response helps strengthen or retrain a muscle after surgery or an injury. Healthcare professionals may recommend TENS therapy to help increase blood flow to the area and reduce pain. This technique help muscle firing patterns.There are also other uses for electrical muscle stimulation, including as an aid for weight loss and physical therapy.
Get access to 250+ pages report
Every segment, forecast, competitor profile and data table behind the analysis above — available for instant download.
- ESOMAR Member
- ISO 9001:2015 Certified
- D-U-N-S Registered
- GDPR & CCPA Compliant
Missing comfort of reading report in your local language? Find your preferred language:
Transform your Strategy with Exclusive Trending Reports
Frequently Asked Questions
The Muscle Stimulation Devices Market is estimated to be valued at USD 848.3 Mn in 2026, and is expected to reach USD 1,116.3 Mn by 2033.
The CAGR of the Muscle Stimulation Devices Market is projected to be 4.0% from 2026 to 2033.
Increasing incidence of head and spinal cord injuries and Increasing product approvals by regulatory bodies for mucle stimulation devices to expand the product portfolio is expected to drive the market growth.
Transcutaneous Electrical Nerve Stimulation (TENS) is the leading segment in the market.
Acceptance of alternative therapies by patients expected to hinder the market over the forecast period.
Major players operating in the market include Baptist Health , DJO Global Inc., Zynex Inc. , Neurometrix Inc., R.S. Medical Inc.,Omron Corporation Medtronic plc., Abbott., Boston Scientific Corporation., BTL Corporate., Nevro Corp., Cogentix Medical and BioMedical Life Systems
